APA (7th ed.) Citation

N, B., M, S., G, L., L, F., L, C., JM, T., . . . B, B. (2025). Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity. British journal of clinical pharmacology, 91(10), 2854. https://doi.org/10.1002/bcp.70103

Chicago Style (17th ed.) Citation

N, Bouazza, et al. "Population Pharmacokinetic Modelling of Prednisolone in Systemic Lupus Erythematosus Patients: Analysis of Exposure and Disease Activity." British Journal of Clinical Pharmacology 91, no. 10 (2025): 2854. https://doi.org/10.1002/bcp.70103.

MLA (9th ed.) Citation

N, Bouazza, et al. "Population Pharmacokinetic Modelling of Prednisolone in Systemic Lupus Erythematosus Patients: Analysis of Exposure and Disease Activity." British Journal of Clinical Pharmacology, vol. 91, no. 10, 2025, p. 2854, https://doi.org/10.1002/bcp.70103.